Analysis
Castelion, a hypersonic-missile startup founded by former SpaceX executives, raised a $1 billion Series C at a $13 billion valuation, co-led by Andreessen Horowitz, Carlyle and JPMorgan Chase, TechCrunch reported. Lightspeed Venture Partners, Lavrock Ventures, Altimeter, General Catalyst and Interlagos also participated, with T. Rowe Price Associates joining as a first-time backer -- a mix of venture, private equity and public-market crossover money that's become common in defense-tech mega-rounds this year.
Industrial-scale capital for an industrial-scale problem
The round's structure is unusual for a venture deal, split between straight equity and a revolving credit facility, per Axios. That split reflects what Castelion is actually building -- physical hardware manufactured at volume, not software shipped at near-zero marginal cost.
“That split reflects what Castelion is actually building -- physical hardware manufactured at volume, not software shipped at near-zero marginal cost.”
- Equity: $800 million of the total
- Revolving credit facility: $250 million of the total
- Prior military contracts secured: $500 million+ since founding in 2022
Founded in 2022 by former SpaceX executives, the Torrance, California company will use the new capital to scale production of its Blackbeard missile at its New Mexico facility, fund development of a longer-range strike weapon, and build out new air and missile defense systems, with Blackbeard fielding targeted for 2027.
The competitive set
Castelion's pitch -- lower-cost hypersonic weapons built faster than the traditional defense-industrial base can move -- puts it in direct competition with Anduril, which has raised at a far higher valuation on a broader autonomous-systems thesis, and with legacy primes like Lockheed Martin and RTX, whose hypersonic programs run on cost-plus government contracts rather than venture capital. A $13 billion mark for a four-year-old company with $500 million in contracts to date is a bet that Castelion can out-execute both on unit economics -- a bet that carries real execution risk until Blackbeard actually fields in 2027.
Defense-tech funding has been on a genuine tear in 2026, and Castelion's round is a data point for VCs watching where the next crop of pre-IPO defense names comes from: the U.S. government's posture toward hypersonic weapons procurement, not just Castelion's own execution, is the variable that determines whether this $13 billion mark holds through the next fundraise.
